Compass Pathways, Transcend Therapeutics, and the Usona Institute have been named the first recipients of FDA National Priority Vouchers following...
President Donald J.
Elephant Gate, a new accelerator launched by Pink Elephant, has opened applications for its inaugural cohort, aiming to support early-stage companies building foundational infrastructure for the...
Japanese pharma company Otsuka Pharmaceutical announced its acquisition of Transcend Therapeutics, Inc.,
The European Medicines Agency is taking steps to rethink how certain high-need medicines reach patients, with a new concept paper proposing a more flexible, evidence-based pathway...
A new clinical trial has found that psilocybin-assisted therapy may be better at helping people stop smoking than standard nicotine replacement treatment.
The U.S.
Clinical updates from Compass Pathways and Helus Pharma from last week marked a significant step forward in the psychedelics development landscape, with new data emerging from...
One of Britain’s central think tanks for drug policy reform is looking for new partners to join forces in 2026.
A new study investigates how so-called “self-transcendent” psychedelic states can trigger enduring changes in meaning-making, values, and perceptions of reality.
